Skip to content

AKTUAPHARMA

Active Public limited companyfounded 1998active for 28 yearsTerhulpsesteenweg 6A, 1560 HoeilaartKBO/BCE: BE 0463.582.004 subsidiary of DOCPHARMA
AKTUAPHARMA
Follow ReportCompare

Timeline

57 events since 1998

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBfull format · 24 days before the deadline
2 directors resigning, 1 statutory auditor resigning, 2 reappointments, 1 reappointmentResignations: DOCPHARMA BV (managing director), Viatris GX BV and Deloitte Bedrijfsrevisoren BV (statutory auditor) · Reappointments: DOCPHARMA BV (managing director), Viatris GX BV and Deloitte Bedrijfsrevisoren BV (statutory auditor) · Permanent representatives: Tomasz Buczek, Arun Narayan and Tom Renders · General meeting of 18-06-202610 points ▸

Open the deed in the Belgian Official Gazette

2025
Permanent representatives: Arun Narayan and Matthew SalzmannBoard meeting of 25-11-20253 points ▸
  • Board meeting, 25-11-2025
  • Permanent representative, Arun Narayan
  • Permanent representative, Matthew Salzmann

Open the deed in the Belgian Official Gazette

Permanent representative: Tomasz BuczekBoard meeting of 23-06-20252 points ▸
  • Board meeting, 23-06-2025
  • Permanent representative, Tomasz Buczek

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFfull format · 34 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 34 days before the deadline
Permanent representatives: Matthew Salzmann and Luis BirbuetBoard meeting of 28-02-20243 points ▸
  • Board meeting, 28-02-2024
  • Permanent representative, Matthew Salzmann
  • Permanent representative, Luis Birbuet

Open the deed in the Belgian Official Gazette

Amendment of the articlesGeneral meeting of 26-12-20232 points ▸
  • General meeting, 26-12-2023
  • Capital, €62,000, 120,000 shares
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

2023
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Gert Vanhees · General meeting of 28-06-20233 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFfull format · 21 days before the deadline
2022
Annual accounts 2021 filed PDFfull format · 24 days before the deadline
2021
Annual accounts 2020 filed PDFfull format · 18 days before the deadline
Permanent representatives: L. Birbuet and José CotareloBoard meeting of 31-03-20213 points ▸
  • Board meeting, 31-03-2021
  • Permanent representative, L. Birbuet
  • Permanent representative, José Cotarelo

Open the deed in the Belgian Official Gazette

2020
Registered in the Peppol Directory Reachable for e-invoices through 0208:0463582004
2 directors reappointed, 1 statutory auditor reappointedDocpharma BV, Mylan BV and Deloitte Bedrijfsrevisoren (statutory auditor) · General meeting of 18-06-20204 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFfull format · 22 days before the deadline
2019
Annual accounts 2018 filed PDFfull format · 22 days before the deadline
Permanent representatives: José Cotarelo, Maximilian von Wülfing, Vincent Verschraegen and Anthonius van 't HullenaarBoard meeting of 20-12-20185 points ▸
  • Board meeting, 20-12-2018
  • Permanent representative, José Cotarelo
  • Permanent representative, Maximilian von Wülfing
  • Permanent representative, Vincent Verschraegen
  • Permanent representative, Anthonius van 't Hullenaar

Open the deed in the Belgian Official Gazette

2018
Annual accounts 2017 filed PDFfull format · 27 days before the deadline
2017
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)General meeting of 30-08-20172 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFfull format · 31 days late
Permanent representatives: M. Von Wülfing and A. van 't HullenaarBoard meeting of 16-03-20173 points ▸
  • Board meeting, 16-03-2017
  • Permanent representative, M. Von Wülfing
  • Permanent representative, A. van 't Hullenaar

Open the deed in the Belgian Official Gazette

2016
Permanent representative: Jens NeuschaeferBoard meeting of 30-08-20162 points ▸
  • Board meeting, 30-08-2016
  • Permanent representative, Jens Neuschaefer

Open the deed in the Belgian Official Gazette

Annual accounts 2015 filed PDFfull format · 29 days late
Permanent representative: Ivo D'AngeloBoard meeting of 11-04-20162 points ▸
  • Board meeting, 11-04-2016
  • Permanent representative, Ivo D'Angelo

Open the deed in the Belgian Official Gazette

2015
Permanent representatives: Yves Brigode and Jacek GlinkaBoard meeting of 09-09-20154 points ▸
  • Board meeting, 31-08-2015
  • Permanent representative, Yves Brigode
  • Board meeting, 09-09-2015
  • Permanent representative, Jacek Glinka

Open the deed in the Belgian Official Gazette

Annual accounts 2014 filed PDFfull format · 42 days before the deadline
Resignation: Gary Sphar (director)Appointment: Mylan BVBA (director) · Mandate compensation: Mylan BVBA · General meeting of 31-12-20145 points ▸
  • General meeting, 31-12-2014
  • Director resignation, Gary Sphar
  • Director appointment, Mylan BVBA
  • Mandate compensation, Mylan BVBA
  • Power of attorney, Karen Laevaert

Open the deed in the Belgian Official Gazette

2014
Reappointments: Docpharma BVBA (director) and Deloitte Bedrijfsrevisoren (statutory auditor)Mandate compensation: Docpharma BVBA · General meeting of 19-06-20145 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2013 filed PDFfull format · 41 days before the deadline
Permanent representative: Khadija BadliBoard meeting of 17-12-20132 points ▸
  • Board meeting, 17-12-2013
  • Permanent representative, Khadija Badli

Open the deed in the Belgian Official Gazette

2013
Back to profit net €372,511 The net result is €372,511, after one loss-making year.
Permanent representatives: Pascale Engelen and Steen VangsgaardBoard meeting of 24-09-20134 points ▸
  • Board meeting, 24-09-2013
  • Permanent representative, Pascale Engelen
  • Permanent representative, Steen Vangsgaard
  • Power of attorney, Karen Laevaert

Open the deed in the Belgian Official Gazette

Annual accounts 2012 filed PDFfull format · 36 days before the deadline
Resignation: Kristin A Kolesar (director)Appointment: Gary Elmer SPHAR (director) · Mandate compensation: Gary Elmer SPHAR · General meeting of 06-05-20134 points ▸

Open the deed in the Belgian Official Gazette

2012
Annual accounts 2011 filed PDFfull format · 32 days before the deadline
2011
Back to profit net €66,376 The net result is €66,376, after 3 loss-making years.
Annual accounts 2010 filed PDFfull format · 38 days late
2 directors appointed, 1 resignation, 1 statutory auditor reappointedResignation: Seshan Srinivasan · Appointments: Kristin Ann KOLESAR and Docpharma BVBA (managing director) · Permanent representative: Pascale Engelen · General meeting of 20-07-201110 points ▸

Open the deed in the Belgian Official Gazette

2010
Permanent representative: Vincent BouldoiresResignation: Prasad Nimmagadda (director) · Board meeting of 20-05-20104 points ▸
  • Board meeting, 20-05-2010
  • Permanent representative, Vincent Bouldoires
  • Power of attorney, Vincent Bouldoires
  • Director resignation, Prasad Nimmagadda

Open the deed in the Belgian Official Gazette

Annual accounts 2009 filed PDFfull format · 261 days late
Amendment of the articlesGeneral meeting of 28-12-20091 point ▸
  • General meeting, 28-12-2009
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Registered office moved from Heverlee to HoeilaartNew registered office: Terhulpsesteenweg 6A, 1560 Hoeilaart · Previous registered office: Ambachtenlaan 13E, 3001 Heverlee · Board meeting of 11-12-20092 points ▸
  • Board meeting, 11-12-2009
  • Registered-office move, Terhulpsesteenweg 6A, 1560 Hoeilaart

Open the deed in the Belgian Official Gazette

2009
Annual accounts 2008 filed PDFfull format · 280 days late
Weakest financial year net -€1.1m The net result drops to -€1.1m, the lowest from 2008 to 2025. It recovers the following year.
2008
Annual accounts 2007 filed PDFfull format · 257 days late
2006
Annual accounts 2006 filed PDFfull format · 59 days late
1 director appointed, 1 resignationResignation: Stijn Van Rompay · Appointment: SVR Invest BVBA · Permanent representative: Stijn Van Rompay · General meeting of 18-11-20054 points ▸

Open the deed in the Belgian Official Gazette

Demerger: AKTUAPHARMA splits off to VALUE PHARMA INTERNATIONALCapital from €18,665.16 to €62,000 · General meeting of 30-03-200610 points ▸
  • General meeting, 30-03-2006
  • Accounting effect, 01-07-2005
  • Capital decrease, €1,543,118.97
  • Capital increase, €43,334.84
  • Capital, €62,000, 120,000 shares
  • Power of attorney, Laurent MEUR
  • Power of attorney, Steven Peters
  • Power of attorney, Koen Feyaerts
  • Power of attorney, Elke Janssens
  • Power of attorney, Jesse Verbist
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

2005
Annual accounts 2005 filed PDFfull format
2004
Annual accounts 2004 filed PDFfull format
2003
Annual accounts 2003 filed PDFfull format
Annual accounts 2002 filed PDFfull format
2001
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
1998
First establishment Terhulpsesteenweg 6A, Hoeilaart
Incorporation published on 30-06-1998

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 16 June 1998, AKTUAPHARMA was incorporated.1 A capital increase in 2006 brought the capital to €62,000.2 In 2010 the registered office moved to Hoeilaart.3 Total assets went from €1,996 in 2018 to €4,167 in 2022.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 15-05-2006
  3. 3Belgian Official Gazette, 08-01-2010
  4. 4National Bank, annual accounts 2018 and 2022

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure